Highly penetrant hereditary cancer syndromes

被引:238
作者
Nagy, R
Sweet, K
Eng, C
机构
[1] Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43221 USA
[2] Ohio State Univ, Human Genet Program, Ctr Comprehens Canc, Div Human Genet,Dept Internal Med, Columbus, OH 43221 USA
关键词
inherited cancer susceptibility; familial cancer syndromes; breast cancer; colon cancer; endocrine neoplasia;
D O I
10.1038/sj.onc.1207714
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Approximately 5-10% of all cancers are inherited, the majority in an autosomal dominant manner with incomplete penetrance. While this is a small fraction of the overall cancer burden worldwide, the molecular genetic discoveries that have resulted from the study of families with heritable cancer have not only changed the way these families are counselled and managed, but have shed light on molecular regulatory pathways important in sporadic tumour development as well. In this review, we consider 10 of the more highly penetrant cancer syndromes, with emphasis on those predisposing to breast, colon, and/or endocrine neoplasia. We discuss the prevalence, penetrance, and tumour spectrum associated with these syndromes, as well as their underlying genetic defects.
引用
收藏
页码:6445 / 6470
页数:26
相关论文
共 367 条
[51]   GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE - CORRELATIONS WITH PHENOTYPE [J].
CHEN, F ;
KISHIDA, T ;
YAO, M ;
HUSTAD, T ;
GLAVAC, D ;
DEAN, M ;
GNARRA, JR ;
ORCUTT, ML ;
DUH, FM ;
GLENN, G ;
GREEN, J ;
HSIA, YE ;
LAMIELL, J ;
LI, H ;
WEI, MH ;
SCHMIDT, L ;
TORY, K ;
KUZMIN, I ;
STACKHOUSE, T ;
LATIF, F ;
LINEHAN, WM ;
LERMAN, M ;
ZBAR, B .
HUMAN MUTATION, 1995, 5 (01) :66-75
[52]   Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells [J].
Chen, JJ ;
Silver, DP ;
Walpita, D ;
Cantor, SB ;
Gazdar, AF ;
Tomlinson, G ;
Couch, FJ ;
Weber, BL ;
Ashley, T ;
Livingston, DM ;
Scully, R .
MOLECULAR CELL, 1998, 2 (03) :317-328
[53]  
Chrousos GP, 1998, J INTERN MED, V243, P573
[54]   The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis [J].
Chung, DC .
GASTROENTEROLOGY, 2000, 119 (03) :854-865
[55]  
CLAUS EB, 1991, AM J HUM GENET, V48, P232
[56]   Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease [J].
Clifford, SC ;
Cockman, ME ;
Smallwood, AC ;
Mole, DR ;
Woodward, ER ;
Maxwell, PH ;
Ratcliffe, PJ ;
Maher, ER .
HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1029-1038
[57]   MALIGNANT POTENTIAL IN INTESTINAL JUVENILE POLYPOSIS SYNDROMES [J].
COBURN, MC ;
PRICOLO, VE ;
DELUCA, FG ;
BLAND, KI .
ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (05) :386-391
[58]   Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types [J].
Corbetta, S ;
Pizzocaro, A ;
Peracchi, M ;
BeckPeccoz, P ;
Faglia, G ;
Spada, A .
CLINICAL ENDOCRINOLOGY, 1997, 47 (05) :507-512
[59]   HIGH ALLELE LOSS RATES AT 17Q12-Q21 IN BREAST AND OVARIAN-TUMORS FROM BRCA1-LINKED FAMILIES [J].
CORNELIS, RS ;
NEUHAUSEN, SL ;
JOHANSSON, O ;
ARASON, A ;
KELSELL, D ;
PONDER, BAJ ;
TONIN, P ;
HAMANN, U ;
LINDBLOM, A ;
LALLE, P ;
LONGY, M ;
OLAH, E ;
SCHERNECK, S ;
BIGNON, YJ ;
SOBOL, H ;
CHANGCLAUDE, J ;
LARSSON, C ;
SPURR, N ;
BORG, A ;
BARKARDOTTIR, RB ;
NAROD, S ;
DEVILEE, P .
GENES CHROMOSOMES & CANCER, 1995, 13 (03) :203-210
[60]   Screening for MEN1 mutations in patients with atypical endocrine neoplasia [J].
Dackiw, APB ;
Cote, GJ ;
Fleming, JB ;
Schultz, PN ;
Stanford, P ;
Vassilopoulou-Sellin, R ;
Evans, DB ;
Gagel, RF ;
Lee, JE .
SURGERY, 1999, 126 (06) :1097-1103